Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Phoenix Arizona 85006

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Sun City Arizona 85351

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

California

Research Center
Additional Locations California

Clinical Research for Patient with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer’s Disease disease

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

PAREXEL
Glendale California 91206

Mild Cognitive Impairment

Alliance Research Center
Laguna Hills California 92653

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Collaborative Neuro Science Network
Long Beach California 90806

Clinical study evaluating treatment for Alzheimer's disease

Renew Behavioral Health, Inc.
Long Beach California 90807

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Excell Research, Inc.
Oceanside California 92056

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Asclepes Research Center
Panorama City California 91402

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Northern California Research
Sacramento California 95821

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)

Schuster Medical Research Institute
Sherman Oaks California 91403

Have you had a slow progression of memory decline in the last year or so?

Schuster Medical Research Institute
Sherman Oaks California 91403

Have you had a slow progression of memory decline in the last year or so?

Research Center
Various Locations California

Clinical Research for Mild Cognitive Impairment (MCI) or Alzheimer’s disease

View More ▼

San Francisco California 94158

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Connecticut

Chase Medical Research, LLC
Waterbury Connecticut 06708

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext (NOURISH AD)

Florida

Bradenton Research Center
Bradenton Florida 34205

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

MD Clinical
Hallandale Beach Florida 33009

Do you know someone with Memory Loss?

New Horizon Research Center
Miami Florida 33175

A 24-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer’s Disease

IMIC, Inc.
Miami Florida 33157

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Panax Clincial Research LLC
Miami Lakes Florida 33014

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Neurostudies, Inc.
Port Charlotte Florida 33952

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Progressive Medical Research
Port Orange Florida 32127

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Stedman Clinical Trials
Tampa Florida 33613

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Orlando Florida 32806

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Tampa Florida 33613

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

The Villages Florida 32162

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Georgia

NeuroStudies.net, LLC
Decatur Georgia 30033

A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease.

NeuroStudies.net, LLC
Decatur Georgia 30033

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease

NeuroStudies.net, LLC
Decatur Georgia 30033

A randomised, double-blind, parallel-group, placebo-controlled, fixed dose study of study drug in patients with mild-moderate Alzheimer's disease treated with donepezil

NeuroStudies.net, LLC
Decatur Georgia 30033

An exploratory, paired biomarker study in subjects with Alzheimer's disease vs. healthy subjects

NeuroStudies.net, LLC
Decatur Georgia 30033

Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers

NeuroStudies.net, LLC
Decatur Georgia 30033

The purpose of the study is to evaluate the safety and tolerability of multiple doses of NPT088 in patients with mild to moderate probable Alzheimer's Disease. The study will also evaluate the pharmacokinetics, immunogenicity and exploratory pharmacodynamic characteristics of multiple doses of NPT088.

View More ▼

Atlanta Georgia 30331

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Atlanta Georgia 30322

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Illinois

Behavioral Health Care Associates
Schaumburg Illinois 60193

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Chicago Illinois 60640

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease

Park Ridge Illinois 60068

A clinical trial seeking patients for a research study for the treatment of Alzheimer's Disease